G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan
· Delayed Price · Currency is TWD 35.15
+0.20 (0.57%)
Apr 29, 2026, 1:30 PM CST
G&E Herbal Biotechnology Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 2,240 | 2,734 | 3,339 | 3,440 | 2,972 | 1,558 | Upgrade
|
| Market Cap Growth | -29.96% | -18.14% | -2.92% | 15.73% | 90.71% | -19.66% | Upgrade
|
| Enterprise Value | 1,810 | 2,323 | 3,017 | 3,226 | 2,849 | 1,446 | Upgrade
|
| Last Close Price | 35.15 | 42.90 | 51.65 | 52.67 | 45.51 | 23.86 | Upgrade
|
| PE Ratio | 16.12 | 19.64 | 32.72 | 47.51 | 402.69 | - | Upgrade
|
| PS Ratio | 7.25 | 8.84 | 13.41 | 18.96 | 46.01 | 63.43 | Upgrade
|
| PB Ratio | 2.41 | 2.95 | 4.01 | 4.51 | 4.30 | 2.28 | Upgrade
|
| P/TBV Ratio | 2.82 | 3.44 | 4.77 | 5.47 | 5.34 | 2.84 | Upgrade
|
| P/FCF Ratio | 33.44 | 40.82 | 25.94 | 31.86 | 30.64 | - | Upgrade
|
| P/OCF Ratio | 31.92 | 38.95 | 24.80 | 30.31 | 29.73 | - | Upgrade
|
| EV/Sales Ratio | 5.86 | 7.52 | 12.12 | 17.78 | 44.10 | 58.83 | Upgrade
|
| EV/EBITDA Ratio | 11.11 | 14.34 | 23.35 | 35.88 | 191.43 | - | Upgrade
|
| EV/EBIT Ratio | 11.89 | 15.25 | 25.22 | 39.98 | 519.39 | - | Upgrade
|
| EV/FCF Ratio | 27.03 | 34.69 | 23.44 | 29.88 | 29.37 | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | - | - | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.01 | 0.02 | - | - | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.01 | 0.01 | 0.02 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.46 | -0.46 | -0.49 | -0.41 | -0.30 | -0.16 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.65 | -2.65 | -3.15 | -3.46 | -13.84 | 10.65 | Upgrade
|
| Net Debt / FCF Ratio | -6.41 | -6.41 | -3.16 | -2.88 | -2.12 | 9.93 | Upgrade
|
| Asset Turnover | 0.32 | 0.32 | 0.27 | 0.22 | 0.09 | 0.04 | Upgrade
|
| Inventory Turnover | 1.95 | 1.95 | 1.96 | 1.55 | 1.14 | 0.81 | Upgrade
|
| Quick Ratio | 9.51 | 9.51 | 3.42 | 2.77 | 2.25 | 13.14 | Upgrade
|
| Current Ratio | 10.09 | 10.09 | 3.61 | 2.97 | 2.54 | 15.66 | Upgrade
|
| Return on Equity (ROE) | 15.80% | 15.80% | 12.78% | 9.96% | 1.07% | -2.87% | Upgrade
|
| Return on Assets (ROA) | 9.84% | 9.84% | 8.12% | 6.05% | 0.46% | -1.74% | Upgrade
|
| Return on Invested Capital (ROIC) | 27.07% | 28.94% | 22.28% | 13.75% | 1.04% | -3.38% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.40% | 16.40% | 14.30% | 10.60% | 0.80% | -2.90% | Upgrade
|
| Earnings Yield | 6.21% | 5.09% | 3.06% | 2.10% | 0.25% | -1.28% | Upgrade
|
| FCF Yield | 2.99% | 2.45% | 3.86% | 3.14% | 3.26% | -0.70% | Upgrade
|
| Dividend Yield | 3.34% | 2.72% | 1.47% | 0.95% | - | - | Upgrade
|
| Payout Ratio | 32.08% | 32.08% | 31.12% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.08% | -0.08% | -0.06% | -0.08% | - | - | Upgrade
|
| Total Shareholder Return | 3.30% | 2.64% | 1.41% | 0.86% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.